Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4934589 | Psychoneuroendocrinology | 2017 | 37 Pages |
Abstract
Our results are in line with previous reports of increased levels of markers of inflammation and oxidative stress in MDD. Moreover, poorer antidepressant treatment response was related to higher baseline levels of the major oxidative stress marker, F2-isoprostanes, in vivo. Further, antidepressant response was associated with changes in oxidative (8-OHdG) and inflammatory (IL-6) markers.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Daniel Lindqvist, Firdaus S. Dhabhar, S. Jill James, Christina M. Hough, Felipe A. Jain, F. Saverio Bersani, Victor I. Reus, Josine E. Verhoeven, Elissa S. Epel, Laura Mahan, Rebecca Rosser, Owen M. Wolkowitz, Synthia H. Mellon,